Lawsuit Targeting Novartis' Macular Degeneration Drug Survives Dismissal in Fla. Federal Court



DOCUMENTS
  • Order


TAMPA, Fla. — A Florida federal judge has refused to dismiss a case targeting Novartis Pharmaceuticals Corp.’s macular degeneration drug Beovu, ruling it is not clear at this stage in the proceedings whether the claims are preempted pursuant to Buckman v. Plaintiffs’ Legal Committee.

In a Sept. 23 order, Judge William Jung of the U.S. District Court for the Middle District of Florida further ruled that the negligent misrepresentation claim has been adequately pled to survive a motion to dismiss.

Kenneth Davison was diagnosed with wet age-related macular degeneration (AMD), a disease in which a patient slowly suffers progressive sight …






UPCOMING CONFERENCES




HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates

May 29, 2024

MORE DETAILS



HarrisMartin's Masters of Mass Tort Settlements Conference - Sponsored by Milestone

June 27, 2024 - Buffalo, NY
The Richardson Hotel Buffalo

MORE DETAILS